EBR Systems Inc - Asset Resilience Ratio
EBR Systems Inc (EBR) has an Asset Resilience Ratio of 54.70% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how EBR Systems Inc's Asset Resilience Ratio has changed over time. Check EBR Systems Inc (EBR) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down EBR Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EBR Systems Inc (EBR) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$5.79 Million | 5.96% |
| Short-term Investments | AU$47.43 Million | 48.75% |
| Total Liquid Assets | AU$53.22 Million | 54.70% |
Asset Resilience Insights
- Very High Liquidity: EBR Systems Inc maintains exceptional liquid asset reserves at 54.70% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
EBR Systems Inc Industry Peers by Asset Resilience Ratio
Compare EBR Systems Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Bactiguard Holding AB (publ)
ST:BACTI-B |
Medical Devices | 8.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
Annual Asset Resilience Ratio for EBR Systems Inc (2019–2025)
The table below shows the annual Asset Resilience Ratio data for EBR Systems Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 54.70% | AU$53.22 Million ≈ $37.66 Million |
AU$97.29 Million ≈ $68.84 Million |
-27.77pp |
| 2024-12-31 | 82.47% | AU$60.66 Million ≈ $42.92 Million |
AU$73.56 Million ≈ $52.05 Million |
-9.19pp |
| 2023-12-31 | 91.66% | AU$72.32 Million ≈ $51.17 Million |
AU$78.90 Million ≈ $55.83 Million |
+3.03pp |
| 2022-12-31 | 88.63% | AU$63.53 Million ≈ $44.95 Million |
AU$71.68 Million ≈ $50.72 Million |
-2.96pp |
| 2021-12-31 | 91.59% | AU$78.24 Million ≈ $55.36 Million |
AU$85.42 Million ≈ $60.44 Million |
+21.60pp |
| 2020-12-31 | 69.99% | AU$5.88 Million ≈ $4.16 Million |
AU$8.40 Million ≈ $5.94 Million |
+11.18pp |
| 2019-12-31 | 58.81% | AU$7.29 Million ≈ $5.15 Million |
AU$12.39 Million ≈ $8.76 Million |
-- |
About EBR Systems Inc
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization thera… Read more